Evaluate Efficacy and Safety of LACUDY for Improving Vaginal Environment in Breast Cancer Patient
Launched by GUN OH CHONG · Dec 6, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
* Registered subjects are 1:1 randomized using a random sequencing generator (www.random.org). Experimental group with 30 patients and Control group with 30 patinets.
* In the case of the experimental group, LACUDY 2mL is inserted twice a week for a month before going to bed for 4 weeks.
* Unpack the product and take it out.
* Remove the cap by turning it.
* Fit the nozzle to the end of the syringe and turn it to combine.
* Hold the syringe with the nozzle facing the vulva, insert it about 5-6 cm into the vagina, and then slowly press the tip of the push rod with patient's thumb to...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Female
- • 2. Aged 20 to 60 years diagnosed with breast cancer
- • 3. Receiving anti-hormonal therapy
- • 4. Patients who subjectively complain of vaginal dryness
- • 5. Patients without current psychiatric problems
- • 6. Patients who can understand and respond to the contents of the questionnaire
- • 7. Ability to provide informed consent
- Exclusion Criteria:
- • 1. Women under 19 and over 61
- • 2. Pregnant woman
- • 3. In case of recurrence or disease progression
- • 4. Patients without sexual experience
- • 5. Unable to provide informed consent
About Gun Oh Chong
Gun Oh Chong is a dedicated clinical trial sponsor focused on advancing medical research and innovation. With a commitment to improving patient outcomes, the organization specializes in the development and management of clinical studies across various therapeutic areas. Leveraging a team of experienced professionals, Gun Oh Chong emphasizes rigorous adherence to regulatory standards and ethical guidelines, ensuring the highest quality in trial execution. Their collaborative approach fosters partnerships with healthcare institutions and researchers, aiming to bring novel therapies from the laboratory to the clinic efficiently and effectively.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials